Yan-Shen Shan, MD, PhD
Distinguished Professor, Institute of Clinical Medicine, National Cheng Kung University
About the Forum
Experts from Taiwan, Japan and the PhilippinesFrom Early Detection to Personalized Treatment
Pancreatic cancer experts from Japan and the Philippines join Taiwan clinical teams to cover the full patient journey, from early screening, diagnosis and risk assessment to multidisciplinary treatment, follow-up and long-term care, together with industry innovations for patient-centered integrated care.
Speakers
Convenors & Moderators
Wei-Chih Liao, MD, PhD
Professor, Internal Medicine, National Taiwan University
Speakers
International Speakers
IASGO
Kyoichi Takaori, MD, PhD
Secretary General
Secretary General, International Association of Pancreatology
CEO, Nagahama City Hospital Enterprise, Japan
Philippine Association of Hepato Pancreato Biliary Surgeons
Avril P. David, MD
Secretary General
Program
Agenda
Session I
International Perspectives & Clinical Advances
-
10:0010:1510:00–10:15Opening Remarks
The Current Development and Future Perspectives for Pancreatic Cancer
- Yan-Shen Shan, MD, PhDDistinguished Professor, Institute of Clinical Medicine, National Cheng Kung University
-
10:1510:3010:15–10:30International Lecture I
Toward Integrated and Multidisciplinary Care for Patients with Pancreatic Cancer: From Early Detection to Personalized Treatment
- Kyoichi Takaori, MD, PhDSecretary General, IASGOSecretary General, International Association of PancreatologyCEO, Nagahama City Hospital Enterprise, Japan
-
10:3010:4510:30–10:45International Lecture II
Integrating HPB Surgery into Multidisciplinary Pancreatic Cancer Care: From Diagnosis to Treatment
- Avril P. David, MDSecretary General, Philippine Association of Hepato Pancreato Biliary Surgeons
-
10:4511:0010:45–11:00Clinical Lecture
Enhancing Diagnosis of Pancreatic Cancer with AI
- Wei-Chih Liao, MD, PhDProfessor, Internal Medicine, National Taiwan University
Session II
Pancreatic Cancer Solution Showcase
-
11:0011:0511:00–11:05Introduction
From Clinical Needs to Integrated Solutions — The Pancreatic Cancer Patient Journey
- Yan-Shen Shan, MD, PhDDistinguished Professor, Institute of Clinical Medicine, National Cheng Kung University
-
11:0511:1011:05–11:10Solution Pitch I
Taiwan Regimen (SLOG) for Advanced Pancreatic Cancer Treatment
- TTY Biopharm Company Limited
-
11:1011:1511:10–11:15Solution Pitch II
PANCREASaver: AI-Powered Early Detection of Pancreatic Cancer
- Fu Jen Catholic University Hospital
-
11:1511:2011:15–11:20Solution Pitch III
Precision Medicine in Pancreatic Cancer
- ACT Genomics
-
11:2011:2511:20–11:25Solution Pitch IV
Comprehensive Cancer Genetic Testing
- GENOMICS BIOSCIENCE & TECHNOLOGY CO., LTD.
-
11:2511:3011:25–11:30Solution Pitch V
Innovative Tumor Microenvironment Reprogramming Therapies for Pancreatic Cancer
- Ti-UNic Biotech Inc., Ltd.
-
11:3011:3511:30–11:35Solution Pitch VI
From ONIVYDE Success to Precision Oncology Innovation in PDAC
- PharmaEngine, Inc.
-
11:3511:4011:35–11:40Closing Remarks
- Yan-Shen Shan, MD, PhDDistinguished Professor, Institute of Clinical Medicine, National Cheng Kung University
Registration
Register Online
CME Credits
- Gastroenterological Society of Taiwan1 credit (Category B)
- Taiwan Society of Digestive SurgeryPending
- Taiwan Oncology SocietyPending
